Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05580588
Title Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shanghai Pharma Biotherapeutics USA Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.